MedTrace Logo

Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds

NCT01417234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-08-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy of the Spiracur SNaP® Wound Care System for the treatment of acute trauma and acute surgical excision wounds. The secondary purpose will be to compare the prospective patients to retrospectively treated acute trauma wounds to further evaluate efficacy and safety.

Conditions

  • Trauma-related Wound
  • Surgical Wound, Recent

Interventions

DEVICE

SNaP® Wound Care System

Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.

Sponsors & Collaborators

  • 3M

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01417234 on ClinicalTrials.gov